Lassa Fever Viral Replication, Disease Pathogenesis, and Host Immune Modulations

Lassa virus causes Lassa fever disease in several countries in West Africa, where it is estimated to infect up to half million people causing roughly five thousand deaths each year. This deadly virus has also been introduced in multiple occasions into the western world, including the United States,...

Full description

Saved in:
Bibliographic Details
Other Authors: Ly, Hinh (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_68880
005 20210501
003 oapen
006 m o d
007 cr|mn|---annan
008 20210501s2020 xx |||||o ||| 0|eng d
020 |a books978-3-03936-610-1 
020 |a 9783039366095 
020 |a 9783039366101 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-03936-610-1  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a GP  |2 bicssc 
072 7 |a PS  |2 bicssc 
100 1 |a Ly, Hinh  |4 edt 
700 1 |a Ly, Hinh  |4 oth 
245 1 0 |a Lassa Fever  |b Viral Replication, Disease Pathogenesis, and Host Immune Modulations 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2020 
300 |a 1 electronic resource (132 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Lassa virus causes Lassa fever disease in several countries in West Africa, where it is estimated to infect up to half million people causing roughly five thousand deaths each year. This deadly virus has also been introduced in multiple occasions into the western world, including the United States, United Kingdom, Netherlands, Sweden, and Germany. Lassa virus infection, which is often misdiagnosed, can lead to a wide range of disease symptoms ranging from mild flu-like symptoms to bleeding disorders, multi-organ failure, and death. Despite some major discoveries made in recent years of research on Lassa fever, there are still many unresolved key issues that hamper the development of effective vaccines and therapies. Some of these issues include a detailed understanding of the viral and participating host factors in completing the virus life cycle, in mediating disease pathogenesis or protection, and in activating or suppressing host immune responses against virus infection. This book is devoted to understanding some of these important issues. Expert and timely contributions in the form of editorial and original research and review articles on Lassa fever viral replication, disease pathogenesis and protection, host immune modulations, and other related hot topics are presented in this publication. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Research & information: general  |2 bicssc 
650 7 |a Biology, life sciences  |2 bicssc 
653 |a Lassa virus disease (LVD) 
653 |a vaccine breadth 
653 |a mimicry 
653 |a B cell anergy 
653 |a conserved antigens 
653 |a Fc-gamma receptors 
653 |a conformational antigens 
653 |a broadly-neutralizing antibodies 
653 |a focused immunity 
653 |a dominant and subdominant epitopes 
653 |a cross-restriction 
653 |a Lassa virus 
653 |a Z protein 
653 |a late domain 
653 |a PPXY 
653 |a budding 
653 |a release 
653 |a matrix protein 
653 |a phosphorylation 
653 |a arenavirus 
653 |a mass spectrometry 
653 |a viral glycoprotein 
653 |a viral entry 
653 |a viral fusion 
653 |a fusion protein 
653 |a Lassa virus vaccine 
653 |a ML29 vaccine 
653 |a STAT-1-/- mice 
653 |a Mopeia virus 
653 |a interfering particles 
653 |a Lassa fever 
653 |a LASV 
653 |a virus-host interactions 
653 |a entry 
653 |a replication 
653 |a Lassa vaccine 
653 |a replication-deficient MVA vector 
653 |a VLP formation 
653 |a single-dose efficacy 
653 |a cell-mediated immunity 
653 |a arenaviruses 
653 |a viral hemorrhagic fevers 
653 |a animal models 
653 |a mammarenavirus 
653 |a vaccine 
653 |a virulence 
653 |a pathogenesis 
653 |a innate immunity 
653 |a adaptive immunity 
653 |a COVID-19 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/2647  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/68880  |7 0  |z DOAB: description of the publication